Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myelomaJo Caers, Karin Vanderkerken|British Journal of Cancer|2008Cited by 35
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone diseaseJoséphine Muller, Jo Caers|Haematologica|2018Cited by 20